Who is this study for?
People who have a rare disease called Pemphigus Vulgaris or people who have a disease called Pemphigus Foliaceus.
Who can participate?
- You may be able to participate if:
- You are between ages 18 and 80
- You have been diagnosed with a moderate to severe Pemphigus Vulgaris or Pemphigus Foliaceus (also called superficial pemphigus)
- You do not have other serious medical conditions and have not recently undergone surgery
What does this study do?
This study will evaluate a drug called Efgartigimod. Researchers want to know how well the drug works; how safe the drug is and how drug effects the people taking it.
Email us at email@example.com or call the PHDermatology Clinical Research Center at 727-250-1125.